[Federal Register Volume 67, Number 60 (Thursday, March 28, 2002)]
[Corrections]
[Page 15011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C2-6767]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Agency

21 CFR Part 1308

[DEA-225P]


Schedule of Controlled Substances: Proposed Rule: Rescheduling of 
Buprenorphine From Schedule V to Schedule III

Correction

    In proposed rule document 02-6767 beginning on page 13114 in the 
issue of Thursday, March 21, 2002, make the following corrections:
    1. On page 1135, in the first column, in the second paragraph, in 
the first line, ``(0.3mg/m1)'' should read, ``(0.3mg/ml)''.
    2. On the same page, in the first column, in the second paragraph, 
in the fifth line, ``Subozone'' should read, 
``Suboxone''.
    3. On the same page, in the second column, in the second paragraph, 
in the thirteenth line, ``table'' should read, ``tablet''.
    4. On the same page, in the same column, in the second paragraph, 
in the 15th line, ``fewer'' should read, ``newer''.
    5. On page 13115, under the heading ``What Is the Effect of This 
Notice?'', in the first paragraph, in the fourth line, ``salts or '' 
should read, `` salts of''.

[FR Doc. C2-6767 Filed 3-27-02; 8:45 am]
BILLING CODE 1505-01-D